Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
Eur J Gynaecol Oncol ; 32(4): 455-6, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21941978

RESUMEN

PURPOSE OF INVESTIGATION: A rare case of increasing CA 125 and CA 19-9 levels increasing in a woman with adenomyoma is described. METHODS: A 39-year-old nullipara woman with CA 125 = 1,796 U/ml and CA 19-9 = 177 U/ml was submitted to abdominal and pelvic MRI, gastric endoscopy, colonoscopy, hysteroscopy, pelvic Doppler and PET scan. None of the exams revealed any apparent malignant disease. RESULTS: Six months of gonadotropin releasing hormone agonist treatment reduced CA 125 and CA 19-9 levels. However, after contraceptive pill use the markers were again elevated, and a laparoscopic hysterectomy was performed, and normal CA 125 and CA 19-9 levels were achieved. CONCLUSIONS: Adenomyoma may be associated with high levels of CA 125 and CA 19-9.


Asunto(s)
Adenomioma/diagnóstico , Adenomioma/terapia , Antígeno Ca-125/sangre , Antígeno CA-19-9/sangre , Neoplasias Ováricas/diagnóstico , Neoplasias Ováricas/terapia , Adenomioma/sangre , Adenomioma/tratamiento farmacológico , Adenomioma/cirugía , Adulto , Relación Dosis-Respuesta a Droga , Femenino , Hormona Liberadora de Gonadotropina/agonistas , Humanos , Neoplasias Ováricas/sangre , Neoplasias Ováricas/tratamiento farmacológico , Neoplasias Ováricas/cirugía , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...